
This week's edition of the Mainstream Patient features stories about tinted sunscreens that don't leave a white cast, laundry detergent for sensitive skin, UPF clothing for summer, and more.

This week's edition of the Mainstream Patient features stories about tinted sunscreens that don't leave a white cast, laundry detergent for sensitive skin, UPF clothing for summer, and more.

In a real-world study, the novel serum REVIVV® showed an increase in hair growth and hair volume.

In part 1 of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

Click here to answer this week's poll.

Women selected will receive mentorship to grow their businesses in a variety of sectors from travel to fashion and everything in between.

ICYMI, this week we had stories about evolving research and treatment options for plaque psoriasis, the role of dermatology PAs, tazarotene lotion for acne, and more.

Lauren Miller, MPAS, PA-C, and Tj Chao, MPAS, PA-C, review how they discuss available treatment options for their plaque psoriasis patients in a recent DermView series.

Researchers tested bovine sialogylcoproteins on human dermal fibroblasts.

In a murine model, application of PALA in topical fashion led to reductions in tumor grades and numbers.

Zoe Diana Draelos, MD, editor in chief of Dermatology Times, reviews dermatology's role in pop culture and social media trends: "Popular skin culture has nothing on us but a new vocabulary."

The research delving into skin conditions affecting patients with skin of color, patients in the LGBTQIA+ community, and patients requiring multidisciplinary treatment continues to grow.

Advanced Dermatology and Cosmetic Surgery utilized a streamlining tool to increase their net profit by $9.5 million in 1 year.

Researchers also identified 50% improvement in appearance with larger spot laser use.

Click here to answer this week's poll.

The current dermatology pipeline includes a wide range of medication classes, from Janus kinase (JAK) inhibitors to tumor necrosis factor inhibitors, to phototherapeutics

The new technique analyzes RNA from infant sebum samples.

Jennifer Orozco, DMSc, PA-C, DFAAPA, oversees the American Academy of Physician Associates and advocates for the role of PAs.

More than $600,000 have been donated to raise awareness of melanoma with the #Stickit2Melanoma pledge.

If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.

Joan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.

Despite this, researchers found that Hsp70 plasma levels did not correlate with the extent of disease.

Level Ex, Inc.'s Top Derm is changing the way dermatologists learn about skin conditions—all through a cell phone screen.

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses of the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.

Roger Ceilley, MD, reviewed his best tips for ensuring the best patient outcomes after surgical procedures at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Cameron guided attendees at the Fall Clinical Dermatology Conference for PAs and NPs on his treatment considerations for psoriasis and pigmentary disorders during his 2 sessions.

Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.

Stein Gold reviewed biologics and JAK inhibitors for AD at Fall Clinical for PAs and NPs, as well as topical and oral agents for tough acne.

Reynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.